Table 3.
Restrictions on inpatient buprenorphine and methadone ordering
| Medication | Restriction on inpatient ordering* | N (%) |
|---|---|---|
| Buprenorphine (n = 22) | No restriction | 10 (45%) |
| Restriction based on provider specialty** | 6 (27%) | |
| Only if receiving treatment prior to admission | 3 (14%) | |
| Only physicians with X-waiver*** | 3 (14%) | |
| Pain management only | 1 (5%) | |
| Methadone (n = 23) | No restriction | 9 (39%) |
| Restriction based on provider specialty** | 10 (43%) | |
| Only if receiving treatment prior to admission | 3 (13%) | |
| Only physicians with X-waiver*** | 2 (9%) |
*Restriction categories are not mutually exclusive, some pharmacies reported multiple restrictions
**Varying combination of hospitalists, psychiatry, addiction medicine, pain specialists
***X-waivers, Drug Abuse Treatment Act of 2000 waiver